From: Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma
Bmi-1 protein
All cases
Low expression
Intensive expression
Normal ovaries
30
30 (100%)
0 (0)
Cystadenomas
29 (97%)
1 (3%)
Borderline tumors
40
36 (90%)
4 (10%)
Invasive carcinomas
179
112 (63%)
67 (37%)